We constructed recombinant wild‐type and mutant UMOD proteins based on genetic sequencing of previously identified patients with ADTKD and tested whether these UMOD mutations reduced their binding affinity for cFH and affected cFH function. This evidence concerns the gene CFH and autosomal dominant medullary cystic kidney disease with or without hyperuricemia.